BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17476148)

  • 1. Elective oophorectomy for benign gynecological disorders.
    Shoupe D; Parker WH; Broder MS; Liu Z; Farquhar C; Berek JS
    Menopause; 2007; 14(3 Pt 2):580-5. PubMed ID: 17476148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Obstet Gynecol; 2005 Aug; 106(2):219-26. PubMed ID: 16055568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Clin Obstet Gynecol; 2007 Jun; 50(2):354-61. PubMed ID: 17513923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective oophorectomy in the gynecological patient: when is it desirable?
    Parker WH; Shoupe D; Broder MS; Liu Z; Farquhar C; Berek JS
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):350-4. PubMed ID: 17625417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
    Hickey M; Ambekar M; Hammond I
    Hum Reprod Update; 2010; 16(2):131-41. PubMed ID: 19793841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health.
    Parker WH
    J Minim Invasive Gynecol; 2010; 17(2):161-6. PubMed ID: 20226402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
    Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does retention of the ovaries improve long-term survival after hysterectomy? The validity of the epidemiological evidence.
    Shapiro S
    Climacteric; 2006 Jun; 9(3):161-3. PubMed ID: 16766428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
    Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
    Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer in women with prior hysterectomy.
    Davis R; Unger JB
    J La State Med Soc; 2003; 155(2):113-5. PubMed ID: 12778998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
    Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
    Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2).
    Dørum A; Tonstad S; Liavaag AH; Michelsen TM; Hildrum B; Dahl AA
    Gynecol Oncol; 2008 Jun; 109(3):377-83. PubMed ID: 18407340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective hysterectomy. Benefits, risks, and costs.
    Sandberg SI; Barnes BA; Weinstein MC; Braun P
    Med Care; 1985 Sep; 23(9):1067-85. PubMed ID: 3928987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
    Rocca WA; Grossardt BR; de Andrade M; Malkasian GD; Melton LJ
    Lancet Oncol; 2006 Oct; 7(10):821-8. PubMed ID: 17012044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease.
    Matthews CA
    J Womens Health (Larchmt); 2013 Sep; 22(9):755-9. PubMed ID: 23865788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
    Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
    Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ovarian preservation in premenopausal women with endometrial cancer.
    Wright JD; Buck AM; Shah M; Burke WM; Schiff PB; Herzog TJ
    J Clin Oncol; 2009 Mar; 27(8):1214-9. PubMed ID: 19171707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer.
    Banerjee S; Kapur S; Moran BJ
    Colorectal Dis; 2005 May; 7(3):214-7. PubMed ID: 15859956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.